A mix COVID-19 booster dose that targets the ancestral pressure of SARS-CoV-2 and the preliminary omicron variant, BA.1, seems to outperform the present booster towards each of these variations of the virus, Moderna reported Wednesday.
Particularly, Moderna says the mixture booster elevated neutralizing antibodies towards omicron 8-fold, whereas the unique booster solely elevated antibody ranges round 4.4-fold.
The vaccine maker is angling to have this bivalent shot—dubbed mRNA-1273.214—be the go-to booster for seasonal pictures this fall. The corporate shall be submitting its information to the Meals and Drug Administration within the coming weeks and says it hopes to have the bivalent booster accessible by late summer season, if not early fall.
Learn 16 remaining paragraphs | Feedback